131 related articles for article (PubMed ID: 28752543)
1. Exonal switch down-regulates the expression of CD5 on blasts of acute T cell leukaemia.
Rai AK; Singh A; Saxena A; Seth T; Raina V; Mitra DK
Clin Exp Immunol; 2017 Dec; 190(3):340-350. PubMed ID: 28752543
[TBL] [Abstract][Full Text] [Related]
2. Jurkat T Cells are Immunophenotypically Distinct from T-Cell Acute Lymphoblastic Leukemia Cells Due to High-Level Surface Expression of CD5.
Singh K; Kumari S; Singh B; Choubey RB; Mitra DK; Rai AK
Cancer Invest; 2022 Sep; 40(8):675-679. PubMed ID: 35758332
[TBL] [Abstract][Full Text] [Related]
3. Selection of the alternative exon 1 from the cd5 gene down-regulates membrane level of the protein in B lymphocytes.
Garaud S; Le Dantec C; Berthou C; Lydyard PM; Youinou P; Renaudineau Y
J Immunol; 2008 Aug; 181(3):2010-8. PubMed ID: 18641338
[TBL] [Abstract][Full Text] [Related]
4. An alternative exon 1 of the CD5 gene regulates CD5 expression in human B lymphocytes.
Renaudineau Y; Hillion S; Saraux A; Mageed RA; Youinou P
Blood; 2005 Oct; 106(8):2781-9. PubMed ID: 15998834
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotypic analysis of T-acute lymphoblastic leukemia. A CD5-based ETP-ALL perspective of non-ETP T-ALL.
Chopra A; Bakhshi S; Pramanik SK; Pandey RM; Singh S; Gajendra S; Gogia A; Chandramohan J; Sharma A; Kumar L; Seth R; Rai S; Kumar R
Eur J Haematol; 2014 Mar; 92(3):211-8. PubMed ID: 24329989
[TBL] [Abstract][Full Text] [Related]
6. Benzo[a]pyrene exposure causes exonal switch resulting in reduced surface CD5 expression in an AHR-dependent manner.
Kumari S; Singh B; Kureel AK; Saini S; Prakash S; Chauhan A; Kumar P; Singh K; Rai AK
Immunol Lett; 2024 Apr; 267():106858. PubMed ID: 38631465
[TBL] [Abstract][Full Text] [Related]
7. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.
Coustan-Smith E; Mullighan CG; Onciu M; Behm FG; Raimondi SC; Pei D; Cheng C; Su X; Rubnitz JE; Basso G; Biondi A; Pui CH; Downing JR; Campana D
Lancet Oncol; 2009 Feb; 10(2):147-56. PubMed ID: 19147408
[TBL] [Abstract][Full Text] [Related]
8. Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.
Han T; Gomez GA; Minowada J
Immunology; 1978 Aug; 35(2):299-305. PubMed ID: 155646
[TBL] [Abstract][Full Text] [Related]
9. Use of colony assays and anti-T cell immunotoxins to elucidate the immunobiologic features of leukemic progenitor cells in T-lineage acute lymphoblastic leukemia.
Uckun FM; Myers DE; Ledbetter JA; Swaim SE; Gajl-Peczalska KJ; Vallera DA
J Immunol; 1988 Mar; 140(6):2103-11. PubMed ID: 3126241
[TBL] [Abstract][Full Text] [Related]
10. Human cytokines suppress apoptosis of leukaemic CD5+ B cells and preserve expression of bcl-2.
Tangye SG; Raison RL
Immunol Cell Biol; 1997 Apr; 75(2):127-35. PubMed ID: 9107564
[TBL] [Abstract][Full Text] [Related]
11. Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor.
Chen KH; Wada M; Pinz KG; Liu H; Lin KW; Jares A; Firor AE; Shuai X; Salman H; Golightly M; Lan F; Senzel L; Leung EL; Jiang X; Ma Y
Leukemia; 2017 Oct; 31(10):2151-2160. PubMed ID: 28074066
[TBL] [Abstract][Full Text] [Related]
12. IL-10 production by B cells expressing CD5 with the alternative exon 1B.
Garaud S; Le Dantec C; de Mendoza AR; Mageed RA; Youinou P; Renaudineau Y
Ann N Y Acad Sci; 2009 Sep; 1173():280-5. PubMed ID: 19758163
[TBL] [Abstract][Full Text] [Related]
13. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation.
Garaud S; Le Dantec C; Jousse-Joulin S; Hanrotel-Saliou C; Saraux A; Mageed RA; Youinou P; Renaudineau Y
J Immunol; 2009 May; 182(9):5623-32. PubMed ID: 19380809
[TBL] [Abstract][Full Text] [Related]
14. Engineered T cells can fight malignant T cells.
Stauss HJ
Blood; 2015 Aug; 126(8):927-8. PubMed ID: 26294714
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of B29 (CD79b) and mb-1 (CD79a) proteins in acute lymphoblastic leukaemia.
Astsaturov IA; Matutes E; Morilla R; Seon BK; Mason DY; Farahat N; Catovsky D
Leukemia; 1996 May; 10(5):769-73. PubMed ID: 8656670
[TBL] [Abstract][Full Text] [Related]
16. CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation.
Garaud S; Morva A; Lemoine S; Hillion S; Bordron A; Pers JO; Berthou C; Mageed RA; Renaudineau Y; Youinou P
J Immunol; 2011 Apr; 186(8):4835-44. PubMed ID: 21398617
[TBL] [Abstract][Full Text] [Related]
17. Hes1 upregulation contributes to the development of FIP1L1-PDGRA-positive leukemia in blast crisis.
Uchida T; Kitaura J; Nakahara F; Togami K; Inoue D; Maehara A; Nishimura K; Kawabata KC; Doki N; Kakihana K; Yoshioka K; Izawa K; Oki T; Sada A; Harada Y; Ohashi K; Katayama Y; Matsui T; Harada H; Kitamura T
Exp Hematol; 2014 May; 42(5):369-379.e3. PubMed ID: 24486648
[TBL] [Abstract][Full Text] [Related]
18. HIF-1α regulates the expression of the non-conventional isoform of the cd5 gene in T cells under the hypoxic condition: A potential mechanism for CD5
Kumari S; Sahu S; Singh B; Gupta S; Kureel AK; Srivastava A; Rikhari D; Srivastava S; Rai AK
Cell Immunol; 2023; 391-392():104755. PubMed ID: 37544247
[TBL] [Abstract][Full Text] [Related]
19. CD123 Immunohistochemical Expression Is a Specific But Insensitive Marker of Early T-precursor Leukemia.
Hellman C; Marcogliese AN; Djokic M; Roth CG
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):e4-5. PubMed ID: 25906118
[No Abstract] [Full Text] [Related]
20. Cytokines and cross-linking of sIgM augment PMA-induced activation of human leukaemic CD5+ B cells.
Tangye SG; Weston KM; Raison RL
Immunol Cell Biol; 1997 Dec; 75(6):561-7. PubMed ID: 9492192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
